STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:STVN - IT0005452658 - Common Stock
21.75 USD
+0.16 (+0.74%)
Taking everything into account, STVN scores 5 out of 10 in our fundamental rating. STVN was compared to 57 industry peers in the Life Sciences Tools & Services industry. STVN scores excellent on profitability, but there are some minor concerns on its financial health. STVN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
STVN had positive earnings in the past year.
STVN had a positive operating cash flow in the past year.
Each year in the past 5 years STVN has been profitable.
In the past 5 years STVN always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 5.71%, STVN belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
The Return On Equity of STVN (9.60%) is better than 78.95% of its industry peers.
STVN's Return On Invested Capital of 7.91% is amongst the best of the industry. STVN outperforms 80.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for STVN is below the industry average of 14.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| ROIC | 7.91% |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
1.3 Margins
Looking at the Profit Margin, with a value of 11.72%, STVN belongs to the top of the industry, outperforming 80.70% of the companies in the same industry.
In the last couple of years the Profit Margin of STVN has grown nicely.
STVN has a better Operating Margin (17.18%) than 80.70% of its industry peers.
STVN's Operating Margin has improved in the last couple of years.
STVN has a Gross Margin of 28.83%. This is in the lower half of the industry: STVN underperforms 75.44% of its industry peers.
STVN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.18% | ||
| PM (TTM) | 11.72% | ||
| GM | 28.83% |
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so STVN is still creating some value.
The number of shares outstanding for STVN has been increased compared to 1 year ago.
Compared to 5 years ago, STVN has less shares outstanding
The debt/assets ratio for STVN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.28 indicates that STVN is not in any danger for bankruptcy at the moment.
STVN has a Altman-Z score of 5.28. This is amongst the best in the industry. STVN outperforms 82.46% of its industry peers.
STVN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
STVN has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.28 |
ROIC/WACC0.86
WACC9.23%
2.3 Liquidity
STVN has a Current Ratio of 1.79. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of STVN (1.79) is worse than 66.67% of its industry peers.
STVN has a Quick Ratio of 1.22. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of STVN (1.22) is worse than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.89% over the past year.
Measured over the past years, STVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.29% on average per year.
Looking at the last year, STVN shows a small growth in Revenue. The Revenue has grown by 6.98% in the last year.
Measured over the past years, STVN shows a quite strong growth in Revenue. The Revenue has been growing by 15.53% on average per year.
EPS 1Y (TTM)14.89%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%16.67%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%9.12%
3.2 Future
Based on estimates for the next years, STVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.33% on average per year.
Based on estimates for the next years, STVN will show a quite strong growth in Revenue. The Revenue will grow by 8.51% on average per year.
EPS Next Y11.64%
EPS Next 2Y16.04%
EPS Next 3Y19.33%
EPS Next 5Y18.33%
Revenue Next Year7.07%
Revenue Next 2Y7.92%
Revenue Next 3Y9%
Revenue Next 5Y8.51%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
STVN is valuated quite expensively with a Price/Earnings ratio of 34.52.
Based on the Price/Earnings ratio, STVN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.17. STVN is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 28.64, which means the current valuation is very expensive for STVN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of STVN indicates a somewhat cheap valuation: STVN is cheaper than 73.68% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of STVN to the average of the S&P500 Index (23.79), we can say STVN is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.52 | ||
| Fwd PE | 28.64 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, STVN is valued a bit cheaper than 75.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
STVN has a very decent profitability rating, which may justify a higher PE ratio.
STVN's earnings are expected to grow with 19.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.97
PEG (5Y)1.27
EPS Next 2Y16.04%
EPS Next 3Y19.33%
5. Dividend
5.1 Amount
With a yearly dividend of 0.31%, STVN is not a good candidate for dividend investing.
STVN's Dividend Yield is rather good when compared to the industry average which is at 0.09. STVN pays more dividend than 85.96% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, STVN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
5.2 History
STVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
10.77% of the earnings are spent on dividend by STVN. This is a low number and sustainable payout ratio.
DP10.77%
EPS Next 2Y16.04%
EPS Next 3Y19.33%
NYSE:STVN (1/7/2026, 11:02:03 AM)
21.75
+0.16 (+0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners110.43%
Inst Owner Change0%
Ins Owners1.61%
Ins Owner ChangeN/A
Market Cap6.59B
Revenue(TTM)1.17B
Net Income(TTM)134.22M
Analysts83.53
Price Target29.57 (35.95%)
Short Float %4.59%
Short Ratio7.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.77%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)2.71%
Max EPS beat(2)10.28%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-7.68%
Max EPS beat(4)10.28%
EPS beat(8)3
Avg EPS beat(8)-5.73%
EPS beat(12)6
Avg EPS beat(12)-2.97%
EPS beat(16)10
Avg EPS beat(16)0.11%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.72%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)2.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.02%
PT rev (1m)-0.69%
PT rev (3m)-0.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)0%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.52 | ||
| Fwd PE | 28.64 | ||
| P/S | 4.9 | ||
| P/FCF | N/A | ||
| P/OCF | 27.14 | ||
| P/B | 4.01 | ||
| P/tB | 4.27 | ||
| EV/EBITDA | 21.28 |
EPS(TTM)0.63
EY2.9%
EPS(NY)0.76
Fwd EY3.49%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.8
OCFY3.68%
SpS4.44
BVpS5.42
TBVpS5.1
PEG (NY)2.97
PEG (5Y)1.27
Graham Number8.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| ROCE | 10.52% | ||
| ROIC | 7.91% | ||
| ROICexc | 8.33% | ||
| ROICexgc | 8.74% | ||
| OM | 17.18% | ||
| PM (TTM) | 11.72% | ||
| GM | 28.83% | ||
| FCFM | N/A |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexgc growth 3Y-28.59%
ROICexgc growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 338.93% | ||
| Cap/Sales | 23.63% | ||
| Interest Coverage | 22.84 | ||
| Cash Conversion | 74.68% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.28 |
F-Score5
WACC9.23%
ROIC/WACC0.86
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%16.67%
EPS Next Y11.64%
EPS Next 2Y16.04%
EPS Next 3Y19.33%
EPS Next 5Y18.33%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%9.12%
Revenue Next Year7.07%
Revenue Next 2Y7.92%
Revenue Next 3Y9%
Revenue Next 5Y8.51%
EBIT growth 1Y6.22%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year69.85%
EBIT Next 3Y33.44%
EBIT Next 5Y24.61%
FCF growth 1Y70.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.91%
OCF growth 3Y5.33%
OCF growth 5Y29.6%
STEVANATO GROUP SPA / STVN FAQ
What is the ChartMill fundamental rating of STEVANATO GROUP SPA (STVN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to STVN.
What is the valuation status of STEVANATO GROUP SPA (STVN) stock?
ChartMill assigns a valuation rating of 3 / 10 to STEVANATO GROUP SPA (STVN). This can be considered as Overvalued.
How profitable is STEVANATO GROUP SPA (STVN) stock?
STEVANATO GROUP SPA (STVN) has a profitability rating of 7 / 10.
Can you provide the financial health for STVN stock?
The financial health rating of STEVANATO GROUP SPA (STVN) is 4 / 10.
Can you provide the dividend sustainability for STVN stock?
The dividend rating of STEVANATO GROUP SPA (STVN) is 3 / 10 and the dividend payout ratio is 10.77%.